Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in adenoid cystic carcinoma of the head and neck: Correlation with clinical outcome

Oral Oncology

Volumn 43, Issue 7, 2007, Pages 662-669

  Chikamatsu, Kazuaki ^a   Shino, Masato ^a   Sakakura, Koichi ^a   Nakajima, Kyoko ^a   Sakurai, Tsutomu ^a   Miyashita, Motoaki ^a   Furuya, Nobuhiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenoic cystic carcinoma; Dihydropyrimidine dehydrogenase; p53; Prognostic factor; Thymidylate synthase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; PROTEIN P53; THYMIDYLATE SYNTHASE;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA, ADENOID CYSTIC; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; THYMIDYLATE SYNTHASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34447332492     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.08.005     Document Type: Article

References (28)

1. Rapidis A.D., Givalos N., Gakiopoulou H., Faratzis G., Stavrianos S.D., Vilos G.A., et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 41 (2005) 328-335
2. Kokemueller H., Eckardt A., Brachvogel P., and Hausamen J.E. Adenoid cystic carcinoma of the head and neck - a 20 years experience. Int J Oral Maxxillofac Surg 33 (2004) 25-31
3. Terhaard C.H.J., Lubsen H., Van der Tweel I., Hilgers F.J.M., Eijkenboom W.M.H., Marres H.A.M., et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26 (2004) 681-693
4. van der Wal J.E., Becking A.G., Snow G.B., and van der Waal I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 24 (2002) 779-783
5. da Cruz Perez D.E., de Abreu Alves F., Nishimoto I.N., de Almeida O.P., and Kowalski L.P. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 42 (2006) 139-146
6. Garden A.S., Weber R.S., Morrison W.H., Ang K.K., and Peters L.J. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Phys 32 (1995) 619-626
7. Chummun S., McLean N.R., Kelly C.G., Dawes P.J.D.K., Meikle D., Fellows S., et al. Adenoid cystic carcinoma of the head and neck. Br J Plast Surg 54 (2001) 476-480
8. El-Naggar A.K., and Huvos A.G. Adenoid cystic carcinoma. In: Barnes L., Evenson J.W., Reichert P., and Sidransky D. (Eds). World Health Organization Classification of tumours: pathology and genetics of head and neck tumours (2005), IARC Press, Lyon 221-222
9. Cho K.J., Lee S.S., and Lee Y.S. Proliferating cell nuclear antigen and c-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 24 (1999) 414-419
10. Lim J.J., Kang S., Lee M.R., Pai H.K., Yoon H.J., Lee J.I., et al. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32 (2003) 552-561
11. Jia L., Esguerra R.L., Tang X., Yin H., Sakamoto K., Okada N., et al. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int 54 (2004) 217-223
12. Banerjee D., Mayer-Kuckuk P., Capiaux G., Budak-Alpdogan T., Gorlick R., and Bertino J.R. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 1587 (2002) 164-173
13. Omura K. Clinical implication of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. Int J Clin Oncol 8 (2003) 132-138
14. Kawasaki G., Yoshitomi I., Yanamoto S., and Mizuno A. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 (2002) 717-723
15. Kobayashi H., Koike T., Nakatsuka A., Kurita H., Sagara J., Taniguchi S., et al. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma. Oral Oncol 41 (2005) 38-47
16. Sakakura K, Chikamatsu K, Shino M, Sakurai T, Furuya N. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in oral squamous cell carcinoma: possible markers as predictors of clinical outcome. Acta Otolaryngol, in press.
17. Arriaga M., Curtin H., Takahashi H., Hirsch B.E., and Kamerer D.B. Staging proposal auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 99 (1990) 714-721
18. Spiro R.H., Huvos A.G., and Strong E.W. Adenoid cystic carcinoma: factors influencing survival. Am J Surg 138 (1979) 579-583
19. Carlinfante G., Lazzaretti M., Ferrari S., Bianchi B., and Crafa P. P53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinico-pathologic study of 21 cases with long-term follow-up. Pathol Res Pract 200 (2005) 791-799
20. Norberg-Spaak L., Dardick I., and Ledin T. Adenoid cystic carcinoma: use of cell proliferation, bcl-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 22 (2000) 489-497
21. Zhang J., Peng B., and Chen X. Expression of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlation with the angiogenesis and clinical outcome. Clin Cancer Res 11 (2005) 7334-7343
22. Allegra C.J., Paik S., Colangelo L.H., Parr A.L., Kirsch I., Kim G., et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute - National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 21 (2003) 241-250
23. Kornmann M., Schwabe W., Sander S., Kron M., Strater J., Polat S., et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res 9 (2003) 4116-4124
24. Ichikawa W., Takahashi T., Suto K., Nihei Z., Shirota Y., Shimizu M., et al. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Int J Cancer 112 (2004) 967-973
25. Shintani Y., Ohta M., Hirabayashi H., Tanaka H., Iuchi K., Nakagawa K., et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer. Lung Cancer 45 (2004) 189-196
26. Kawano K., Yanagisawa S., Kusukawa J., Sunagawa H., Shiba R., Goto M., et al. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study. Int J Oral Maxxilofac Surg 35 (2006) 258-264
27. Kiyoshima T., Shima K., Kobayashi I., Matsuo K., Okamura K., Komatsu S., et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary gland. Oral Oncol 37 (2001) 315-322
28. Alves F.A., Pires F.R., de Almeida O.P., Lopes M.A., and Kowalski L.P. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg 33 (2004) 593-597